Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Free Report) in a research note issued to investors on Monday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Performance EGRX opened at $1.17 on Monday. Eagle Pharmaceuticals has a 52-week low of $0.00 and a 52-week high […]
StockNews.com started coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Free Report) in a research note issued to investors on Monday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Performance EGRX opened at $1.17 on Monday. Eagle Pharmaceuticals has a 52-week low of $0.00 and a 52-week high […]
